Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Intelligent Bio Solutions (INBS) Shares Issued (2020 - 2025)

Intelligent Bio Solutions has reported Shares Issued over the past 2 years, most recently at -$5.3 million for Q2 2024.

For Q2 2024, Shares Issued changed N/A year-over-year to -$5.3 million; the TTM value through Jun 2024 reached $2.4 million, down 36.81%, while the annual FY2024 figure was $3.8 million, 48.22% up from the prior year.
Shares Issued for Q2 2024 was -$5.3 million at Intelligent Bio Solutions, down from $7.8 million in the prior quarter.
Over five years, Shares Issued peaked at $7.8 million in Q1 2024 and troughed at -$5.3 million in Q2 2024.